Lannett

Philadelphia, United States Founded: 1942 • Age: 84 yrs Listed
Generic pharmaceuticals are manufactured, and CDMO services are offered.

About Lannett

Lannett is a publicly listed company based in Philadelphia (United States) founded in 1942. Generic pharmaceuticals are manufactured, and CDMO services are offered. Lannett has completed 2 acquisitions, including Kremers Urban Pharmaceuticals and Silarx Pharmaceuticals. Its chief executive, as recorded, is Timothy Crew. Its website lannett.com draws about 18 thousand monthly visits. Lannett offers products and services including Generic Pharmaceuticals and CDMO Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Lannett Company, Inc.

Company details

Lannett was founded in 1942 and is headquartered in Philadelphia, United States. Operations focus on the pharmaceutical sector, where generic medications for multiple therapeutic areas are developed and produced. Contract development and manufacturing organization (CDMO) services are provided to partners, including collaborations on co-development, distribution agreements, licensing arrangements, and acquisitions. Emphasis is placed on quality and affordability in product delivery.

  • Headquarters Philadelphia, United States
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website lannett.com
  • Social LinkedIn
  • Legal Name Lannett Company, Inc
Key Metrics
  • Annual Revenue
    $340.58 M (USD)
    -29
    as on Jun 30, 2022
  • Net Profit
    -$231.62 M (USD)
    36
    as on Jun 30, 2022
  • EBITDA
    -$176.27 M (USD)
    26
    as on Jun 30, 2022
  • Latest Funding Round
    $27.96M (USD), Post-IPO

    May 2021

  • Investments & Acquisitions

Products & Services of Lannett

Lannett offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals and CDMO Services.

Generic Pharmaceuticals
Healthcare Products

Generic drugs are manufactured and supplied by Lannett for various therapeutic needs, focusing on affordability and quality

CDMO Services
Manufacturing Services

Contract development and manufacturing services are provided by Lannett to support the creation of pharmaceutical products for partners

Funding Insights of Lannett

  • Total Rounds 3
  • Last Round Post-IPO β€” $27.96M
  • First Round $30.5M

    (May 2019)

All 3 funding rounds of Lannett with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2021$27.96MPost-IPO––
–
Sep 2019$86.25MPost-IPO––
–
May 2019$30.5MDebt – Conventional––
–

People of Lannett

61 people are tracked at Lannett (23 in leadership, 3 in board & advisors, 35 in team).

NameRoleGroup
Timothy Crew
CEOLeadership
Samuel H. Israel
Chief Legal Officer & General CounselLeadership
Timothy C. Crew
CEOLeadership
Kristie Stephens
VP of Regulatory AffairsLeadership
Maureen Cavanaugh
SVP & Chief Commercial Operations OfficerLeadership
Michael Block
VP of Business DevelopmentLeadership
Eliene Smith
Director Of Internal AuditLeadership
Tracy Sullivan
Senior Director, National AccountsLeadership
Kristin Arnold
VP Reseach And DevelopmentLeadership
Freddy Rosado
Director, Pricing And ContractsLeadership
Matt Thompson
Director, Sales & Operation PlanningLeadership
Helen Libman
Senior Director, Analytical R&dLeadership
John M. Abt
VP & Chief Quality Operations OfficerLeadership
Kevin Higgins
Director Corporate Quality ControlLeadership
Thomas Lewis
Vice President Of Global Supply Chain And CDMO ManagementLeadership
Bill Giannone
Vp, Marketing And Commercial Operations, Generics And BiosimilarsLeadership
Grant Brock
Chief Operations And Strategy OfficerLeadership
Karen Feldtmose
Senior Director Portfolio DevelopmentLeadership
Keith Collins
Director Quality OperationsLeadership
Tony Meehan
Chief Financial OfficerLeadership

41 more people are available in the full profile.

Premium access

Complete people profiles for Lannett

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lannett

Lannett has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Kremers Urban Pharmaceuticals and Silarx Pharmaceuticals.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Specialty generic drugs are manufactured by Kremers Urban Pharmaceuticals.
kremersurban.comSeymour, United States1904Sep 2015$1.23B
Manufacturer of generic drugs
silarx.comValley Cottage, United States1987May 2015β€’β€’β€’β€’
Premium access

Complete acquisition details for Lannett

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Lannett

6 dated milestones of Lannett across 79 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lannett is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Silarx Pharmaceuticals.
  4. Acquisition Acquires Kremers Urban Pharmaceuticals.
  5. Funding First funding round of $30.5M.
  6. Funding Latest funding round, Post-IPO, of $28.0M.

Web traffic of Lannett

The website of Lannett (lannett.com) receives about 18.2K visits a month and ranks #1,443,152 among all websites worldwide, #1,872 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    18.2K

    ▲ 12.8% vs previous month

  • Unique visitors
    8.2K

    per month

  • Global rank
    #1,443,152

    among all websites

  • Category rank
    #1,872

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Lannett. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
tevausa.com
100%
63.7K#703,532View details
hemispherx.net
hemispherx.net
96%
#13,055,489–
impaxlabs.com
86%
View details
hauserpharmaceutical.com
86%
1.9K#8,413,504View details
globalphar.com
globalphar.com
85%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 16 similar websites and full traffic analytics for Lannett

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Lannett (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lannett

Premium access

Complete news archive for Lannett

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lannett

Lannett was founded in 1942 and raised its 1st funding round 77 years after it was founded.

Lannett is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

Timothy Crew is the CEO of Lannett, as recorded in our data.

Annual revenue of Lannett is $340.58M as on Jun 30, 2022.

Lannett was founded in 1942 and is headquartered in Philadelphia, United States. Operations focus on the pharmaceutical sector, where generic medications for multiple therapeutic areas are developed and produced. Contract development and manufacturing organization (CDMO) services are provided to partners, including collaborations on co-development, distribution agreements, licensing arrangements, and acquisitions. Emphasis is placed on quality and affordability in product delivery.

Lannett offers Generic Pharmaceuticals and CDMO Services.

Lannett has made 2 acquisitions, including Kremers Urban Pharmaceuticals, and Silarx Pharmaceuticals.

Lannett operates through Lannett Company, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available